| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $6.8M | +81.0% |
| SG&A Expense | $5.2M | +15.5% |
| Operating Income | -$12.0M | -45.4% |
| Income Tax | $3K | +50.0% |
| Net Income | -$12.0M | -45.7% |
| EPS (Basic) | -$121.80 | -120.6% |
| EPS (Diluted) | -$121.80 | -120.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.2M | +63.7% |
| Current Assets | $8.6M | +53.0% |
| Total Assets | $8.7M | +51.0% |
| Current Liabilities | $2.6M | +61.6% |
| Total Liabilities | $2.7M | +55.7% |
| Stockholders' Equity | $6.0M | +49.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.2M | -18.3% |
| Capital Expenditures | $3K | — |
| Investing Cash Flow | -$3K | — |
| Financing Cash Flow | $13.4M | +13.2% |
| Free Cash Flow | -$10.2M | -18.3% |